Corvus Pharmaceuticals, Inc. (CRVS)

16.57 -0.96 (-5.48%) USD  |  NASDAQ  |  Feb 20, 16:00
16.65 +0.08 (+0.48%) After-Hours: 07:49
More

Corvus Pharmaceuticals Annual EBITDA Margin Estimates

Annual EBITDA Margin Estimates Chart

View Annual EBITDA Margin Estimates for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EBITDA Margin Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EBITDA Margin Estimates Range, Past 5 Years

View Annual EBITDA Margin Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EBITDA Margin Estimates Benchmarks

View Annual EBITDA Margin Estimates Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Jaguar Health, Inc. Upgrade
Krystal Biotech, Inc. Upgrade